drug

ABI-1179

Phase 1updated 3mo ago

by $GILD GILEAD SCIENCES, INC.

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ABI-1179

phase1A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpescompletedn=103

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 47m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

ABI-1179

Phase 1updated 3mo ago

by $GILD GILEAD SCIENCES, INC.

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ABI-1179

phase1A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpescompletedn=103

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 47m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

ABI-1179

all catalysts(0)

Trials studying ABI-1179

News(0)

Report a data issue

comments(0)

ABI-1179

all catalysts(0)

Trials studying ABI-1179

News(0)

Report a data issue

comments(0)